These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16476788)

  • 1. Catalase activity in Candida albicans exposed to antineoplastic drugs.
    Linares CEB; Griebeler D; Cargnelutti D; Alves SH; Morsch VM; Schetinger MRC
    J Med Microbiol; 2006 Mar; 55(Pt 3):259-262. PubMed ID: 16476788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.
    Linares CE; Giacomelli SR; Altenhofen D; Alves SH; Morsch VM; Schetinger MR
    Rev Soc Bras Med Trop; 2013; 46(6):752-8. PubMed ID: 24474018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of Candida cell virulence by anticancer drugs and irradiation.
    Ueta E; Tanida T; Yoneda K; Yamamoto T; Osaki T
    Oral Microbiol Immunol; 2001 Aug; 16(4):243-9. PubMed ID: 11442850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
    Warnock DW; Johnson EM; Burke J; Pracharktam R
    J Antimicrob Chemother; 1989 Jun; 23(6):837-47. PubMed ID: 2547749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
    Valentín A; Cantón E; Pemán J; Quindós G
    Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal drug susceptibility of Candida albicans.
    Bii CC; Ouko TT; Amukoye E; Githinji LW
    East Afr Med J; 2002 Mar; 79(3):143-5. PubMed ID: 12389961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of peroxisome proliferation and increase of catalase activity in yeast, Candida albicans, by cadmium.
    Chen T; Li W; Schulz PJ; Furst A; Chien PK
    Biol Trace Elem Res; 1995 Nov; 50(2):125-33. PubMed ID: 8605080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans.
    Kohli A; Gupta V; Krishnamurthy S; Hasnain SE; Prasad R
    J Biosci; 2001 Sep; 26(3):333-9. PubMed ID: 11568478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of sulfa drugs and dihydrofolate reductase inhibitors against Candida albicans.
    Bush K; Freudenberger JS; Slusarchyk DS; Sykes RB; Meyers E
    Experientia; 1982 Apr; 38(4):436-7. PubMed ID: 7044814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antineoplastic agents on the growth and ultrastructure of Candida albicans.
    Ghannoum MA; Al-Khars A
    Mykosen; 1984 Sep; 27(9):452-64. PubMed ID: 6438503
    [No Abstract]   [Full Text] [Related]  

  • 13. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth.
    Ghannoum MA; Abu-Elteen KH; Motawy MS; Abu-Hatab MA; Ibrahim AS; Criddle RS
    Chemotherapy; 1990; 36(4):308-20. PubMed ID: 2253499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
    Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G; Turner V; Schulz B; Storch U; Froelich D; Rognon B; Coste AT; Sanglard D; Ruhnke M
    Med Mycol; 2011 Feb; 49(2):132-42. PubMed ID: 20818920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.